pantethine and Hyperlipoproteinemia Type II

pantethine has been researched along with Hyperlipoproteinemia Type II in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	5 (100.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Arsenio, L; Bodria, P; Magnati, G; Strata, A; Trovato, R	1
Balestreri, R; Bertolini, S; Cuzzolaro, S; Daga, A; Donati, C; Elicio, N; Marcenaro, A; Saturnino, M	1
Abbate, R; Gensini, GF; Matucci, M; Neri Serneri, GG; Paniccia, R; Prisco, D; Rogasi, PG	1
Chierchia, I; Cicerano, U; Mancini, M; Postiglione, A; Rubba, P	1
Gensini, GF; Matucci, M; Neri Serneri, GG; Prisco, D; Rogasi, PG	1

Trials

2 trial(s) available for pantethine and Hyperlipoproteinemia Type II

Article	Year
Effect of oral treatment with pantethine on platelet and plasma phospholipids in IIa hyperlipoproteinemia. Angiology, 1987, Volume: 38, Issue:3 Topics: Administration, Oral; Adult; Aged; Blood Platelets; Clinical Trials as Topic; Double-Blind Method; Fatty Acids; Female; Humans; Hyperlipoproteinemia Type II; Male; Middle Aged; Pantetheine; Phosphatidylcholines; Phospholipids; Sphingomyelins; Sulfhydryl Compounds	1987
Pantethine versus fenofibrate in the treatment of type II hyperlipoproteinemia. Monographs on atherosclerosis, 1985, Volume: 13 Topics: Clinical Trials as Topic; Double-Blind Method; Female; Fenofibrate; Humans; Hyperlipoproteinemia Type II; Lipids; Lipoproteins; Male; Pantetheine; Propionates; Random Allocation; Sulfhydryl Compounds	1985

Article

Year

Effect of oral treatment with pantethine on platelet and plasma phospholipids in IIa hyperlipoproteinemia.

Angiology, 1987, Volume: 38, Issue:3

Topics: Administration, Oral; Adult; Aged; Blood Platelets; Clinical Trials as Topic; Double-Blind Method; Fatty Acids; Female; Humans; Hyperlipoproteinemia Type II; Male; Middle Aged; Pantetheine; Phosphatidylcholines; Phospholipids; Sphingomyelins; Sulfhydryl Compounds

1987

Pantethine versus fenofibrate in the treatment of type II hyperlipoproteinemia.

Monographs on atherosclerosis, 1985, Volume: 13

Topics: Clinical Trials as Topic; Double-Blind Method; Female; Fenofibrate; Humans; Hyperlipoproteinemia Type II; Lipids; Lipoproteins; Male; Pantetheine; Propionates; Random Allocation; Sulfhydryl Compounds

1985

Other Studies

3 other study(ies) available for pantethine and Hyperlipoproteinemia Type II

Article	Year
Effectiveness of long-term treatment with pantethine in patients with dyslipidemia. Clinical therapeutics, 1986, Volume: 8, Issue:5 Topics: Cholesterol; Female; Humans; Hyperlipidemias; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type IV; Long-Term Care; Male; Middle Aged; Pantetheine; Sulfhydryl Compounds; Triglycerides	1986
Lipoprotein changes induced by pantethine in hyperlipoproteinemic patients: adults and children. International journal of clinical pharmacology, therapy, and toxicology, 1986, Volume: 24, Issue:11 Topics: Adolescent; Adult; Aged; Apolipoprotein A-I; Apolipoproteins A; Apolipoproteins B; Child; Cholesterol; Female; Humans; Hypercholesterolemia; Hyperlipoproteinemia Type II; Lipoproteins; Male; Middle Aged; Pantetheine; Sulfhydryl Compounds; Triglycerides	1986
Changes in fatty acid composition of the single platelet phospholipids induced by pantethine treatment. International journal of clinical pharmacology research, 1985, Volume: 5, Issue:5 Topics: Administration, Oral; Adult; Aged; Blood Platelets; Cholesterol; Cholesterol, HDL; Chromatography, Gas; Fatty Acids; Female; Humans; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type IV; Male; Middle Aged; Pantetheine; Phosphatidylcholines; Phosphatidylethanolamines; Phospholipids; Sulfhydryl Compounds; Triglycerides	1985